2021
DOI: 10.1111/1759-7714.13891
|View full text |Cite
|
Sign up to set email alerts
|

Simultaneous integrated boost for mediastinal lymph node recurrence after radical surgery for esophageal cancer: Interim results from a phase I/II prospective study

Abstract: Background This was a single institute, phase I/II study of salvage chemoradiotherapy (CRT) with simultaneous integrated boost in patients with mediastinal lymph node (LN) recurrence after esophagectomy. Methods Patients who presented with a clinical diagnosis of ≤5 mediastinal LN recurrence received three consecutive levels of radiotherapy dose for the recurrences. Level 1: 58.8 Gy/2.1 Gy/28 fractions, Level 2: 64.4 Gy/2.3 Gy/28 fractions and Level 3: 70 Gy/2.5 Gy/28 fractions. Results A total of 17 patients … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 20 publications
0
1
0
Order By: Relevance
“…The study was designed as a retrospective design from our prospective trials (NCT NCT04435197, NCT04435197, NCT04513418, NCT03990532) (25)(26)(27), and all included patients were treated with nCRT and PD-1 inhibitors followed by esophagectomy at Ruijin Hospital, Shanghai Jiao Tong university school of medicine, between Jan 2019 and July 2023. All included patients received standardized neoadjuvant chemoradiotherapy.…”
Section: Study Papulationmentioning
confidence: 99%
“…The study was designed as a retrospective design from our prospective trials (NCT NCT04435197, NCT04435197, NCT04513418, NCT03990532) (25)(26)(27), and all included patients were treated with nCRT and PD-1 inhibitors followed by esophagectomy at Ruijin Hospital, Shanghai Jiao Tong university school of medicine, between Jan 2019 and July 2023. All included patients received standardized neoadjuvant chemoradiotherapy.…”
Section: Study Papulationmentioning
confidence: 99%